Direct Funds

Avantea was established in 2008 by Mr. Cesare Galli and Mrs. Giovanna Lazzari, two internationally renowned researchers active in the biotech sector since 1991. The company is the global leader in the equine assisted reproduction with a focus on ICSI (“Intracytoplasmic Sperm Injection”) technology. Avantea operates in partnership with major veterinary clinics, that externalize the ICSI procedure to the company, while covering all other stages of the assisted breeding procedure. Avantea proposition includes also a complete service thanks to the availability of several recipient mares housed in the Cremona breeding facility, which covers 3 hectares and was completely renovated in 2022. The company currently has a turnover of EUR 10 million, of which around 80% generated in foreign markets. Avantea has a significant presence in Belgium, the Netherlands, France and Hungary.
Corporate Video